Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1[Siponimod 0, 25 mg]
(D11460)		[1] Siponimod[2] Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
2[Siponimod 2 mg]
(D11460)		[1] Siponimod[2] Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
3[Siponimod]
(D11460)		[1] Siponimod[2] Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
4Other: Glatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod
(D11460)		[7] Acetate,
Fingolimod,
Glatiramer,
Ozanimod,
Ponesimod,
Siponimod,
Teriflunomide		[10] Fingolimod hydrochloride ,
Glatiramer acetate ,
Fingolimod ,
Teriflunomide ,
Ozanimod hydrochloride ,
Ozanimod ,
Siponimod fumarate ,
Ponesimod ,
Siponimod (D11460),
Fingolimod lauryl sulfate 💬 		[26] DHODH,
HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[37] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Efferocytosis, Endocytosis, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagocytosis, Pyrimidine metabolism, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
5Other: Siponimod
(D11460)		[1] Siponimod[2] Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
6SIPONIMOD
(D11460)		[1] Siponimod[2] Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 50 💬
7Siponimod 0,25 mg
(D11460)		[1] Siponimod[2] Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
8Siponimod 0.25 mg tablet
(D11460)		[1] Siponimod[2] Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 50 💬
9Siponimod 0.5 mg tablet
(D11460)		[1] Siponimod[2] Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 50 💬
10Siponimod 1 mg
(D11460)		[1] Siponimod[2] Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
11Siponimod 1 mg tablet
(D11460)		[1] Siponimod[2] Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 50 💬
12Siponimod 2 mg
(D11460)		[1] Siponimod[2] Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
13Siponimod 2 mg tablet
(D11460)		[1] Siponimod[2] Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 50 💬
14Siponimod fumarato
(D11460)		[1] Siponimod[2] Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬
15SIPONIMOD FUMARIC ACID
(D11460)		[2] Fumaric acid,
Siponimod		[3] Fumaric acid ,
Siponimod fumarate ,
Siponimod (D11460) 💬 		[2] S1PR1,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13 💬